Psoriatic Arthritis
News
Interleukin-23 inhibition with tildrakizumab achieves significant psoriasis improvements
Video
VIDEO: Secukinumab ‘exciting’ new agent for psoriasis
News
Infliximab most common cause of drug-induced liver injury
Key clinical point: Infliximab was the most common anti–tumor necrosis factor-alpha agent linked to liver injury. Major finding: Rates of drug-...
Conference Coverage
New psoriasis drugs offer treatment advantages
Conference Coverage
Data suggest link between tonsillectomy, psoriasis improvement
News
Ixekizumab improves lesions in patients with chronic plaque psoriasis after 20 weeks
News
Unique psoriatic arthritis genetic risk loci discovered
Rheum in Bloom
Methotrexate coverage woes
News
Most cost-effective psoriasis treatment: methotrexate
Conference Coverage
Survey: Psoriasis/psoriatic arthritis undertreated
Key clinical point: Psoriasis and psoriatic arthritis treatment algorithms are underused, and patients are often undertreated. Major finding:...